# FDA Inspection 822697 - Pierre Fabre Medicament - March 14, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/1f1c80d6-dba7-419b-8096-2caf80c9f80c
Source feed: FDA_Inspections

> FDA Inspection 822697 for Pierre Fabre Medicament on March 14, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822697
- Company Name: Pierre Fabre Medicament
- Inspection Date: 2013-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287242 - 2022-07-08](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/7b202fe2-cbe7-4cf2-9f48-14ef3b34b38d)
- [FDA Inspection 1094312 - 2018-07-13](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/57dd8a98-078f-4304-9180-b54ea9c3f9c7)
- [FDA Inspection 970600 - 2016-04-15](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/22e19e7c-24ab-4fd4-9b4e-8f60ed51f9e4)

Company: https://www.globalkeysolutions.net/companies/pierre-fabre-medicament/6c1f31d4-d9f5-478e-99f6-4a0b18be71b5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c